抗HIV治療管理における2つの方法の比較（SMART研究）

基本情報

NCT ID

NCT00027352

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

6,000

治験依頼者名

National Institute of Allergy and Infectious Diseases (NIAID)

概要

The purpose of this study is to compare two ways of using anti-HIV drugs to help health care providers and patients decide how to best use anti-HIV treatments over many years. Many health care providers now treat patients with daily drugs to keep the viral load as low as possible. This approach helps patients with CD4 counts less than 200-250 cells/mm3 live longer without serious diseases. But it is not known if this is the best way to treat patients with higher CD4 counts. There is information suggesting that these patients may be able to wait to use anti-HIV drugs while CD4 counts are above 250 cells/mm3. Because this study will be carried out over several years, it will provide information on the long-term advantages and disadvantages of these two treatment strategies.

対象疾患

依頼者（Sponsor）

実施施設 (2)